Search
Now showing items 11-20 of 271
PHARMACOKINETIC PROFILE OF 2 DIFFERENT PHARMACEUTICAL FORMS OF THEOPHYLLINE (A SLOW-RELEASE TABLET AND A SYRUP) AFTER MULTIPLE-DOSE ADMINISTRATION TO HEALTHY-HUMAN VOLUNTEERS
(Mem Inst Oswaldo CruzRio De JaneiroBrasil, 1993)
Design and evaluation of a controlled-release theophylline tablet preliminary communication
(1989)
A 300 mg controlled-release theophylline formulation was developed as a tablet prepared by wet granulation using the acrylic resins Eudragit S 100(R) and Eudragit RSPM(R). The tablet was compared with a marketed ...
Absolute bioavailability determination of a sustained release theophylline DETERMINACION DE LA BIODISPONIBILIDAD ABSOLUTA DE UN COMPRIMIDO DE LIBERACION CONTROLADA DE TEOFILINA
(1993)
The absolute biovailability of a sustained release tablet developed in our laboratory was evaluated. The formulation employs acrylic resins Eudragit as the sustaining release system and tablets were obtained using conventional ...
Pharmacokinetic profile of two different pharmaceutical forms of theophylline (a slow release tablet and a syrup) after multiple dose administration to healthy human volunteers
(Instituto Oswaldo Cruz, Ministério da Saúde, 1993)
THEOPHYLLINE THERAPY INHIBITS NEUTROPHIL AND MONONUCLEAR CELL CHEMOTAXIS FROM CHRONIC ASTHMATIC-CHILDREN
(Blackwell Science LtdOxfordInglaterra, 1991)
Effect of theophylline on nuclear retention of oestrogen-receptor complexes: correlation with oestrogen responses
(1985)
In the ovariectomized adult rat uterine oedema induced by 0.01 and 0.1 μg oestradiol-17β/100 g body weight increased further in the presence of theophylline. Nuclear retention of oestrogen-receptor complexes also increased ...